# Sofosbuvir + Velpatasvir + Voxilaprevir

## Vosevi 400/100/100mg

##### 臨採

| TAH Drug Code      | [OVOS](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OVOS                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of adult patients with chronic hepatitis C virus (HCV) infection without cirrhosis or with compensated cirrhosis (Child-Pugh A) who have: (1) genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an HCV regimen containing an NS5A inhibitor. (2) genotype 1a or 3 infection and have previously been treated with an HCV regimen containing sofosbuvir without an NS5A inhibitor. |
| Dosing             | One tablet contains sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100mg. 1 tablet once daily with meal for 12 weeks.                                                                                                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Concomitant use with rifampin. Hypersetitivity to Sofosbuvir/Velpatasvir/Voxilaprevir or any ingredients of this product.                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Common Gastrointestinal: Diarrhea (13% to 14% ), Nausea Neurologic: Headache (21% to 23% ) Other: Fatigue (17% to 19% ) Serious Cardiovascular: Bradyarrhythmia, Cardiac arrest Hepatic: Decreased liver function, Liver failure, Reactivation of hepatitis B viral hepatitis                                                                                                                                          |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/sofosbuvir-and-velpatasvir-and-voxilaprevir-drug-information)                                                                                                                                                                                                                                                                                                             |

